BCAN Webinar: “Tobacco and Bladder Cancer: Cigarettes, E-cigarettes, and Why Quitting is So Important”

Smoking is the only preventable cause of bladder cancer and is a well-known risk for complications. Continued cigarette use increases the risk of bladder cancer coming back. The risk association between e-cigarettes and smokeless tobacco and bladder cancer is less well known. People who use electronic cigarettes (e-cigarettes) may have similar carcinogens in their urine as cigarette smokers that are linked to bladder cancer, according to study findings published in European Urology Oncology.

Join Richard Matulewicz, MD and Marc Bjurlin, DO, MSC, FCOS who will discuss:

• The risks of smoking before and after a bladder cancer diagnosis.
• Emerging research about e-cigarettes and carcinogens
• What happens when bladder cancer patients quit smoking
• Tips for quitting smoking
• Q & A

Register Now

Richard Matulewicz, MD
Dr. Matulewicz is a fellowship-trained urologic oncologist and health services researcher at NYU Grossman School of Medicine in the Departments of Urology and Population Health and the VA NY Harbor Health System (NYHHS). Dr. Matulewicz is interested in the intersection of modifiable risk factors and the assessment, diagnosis, and treatment of urologic malignancies. Dr. Matulewicz’s research focuses on improving the delivery of effective smoking cessation interventions to patients with smoking-related urologic malignancies and developing novel risk-stratification approaches for patients undergoing urologic evaluation for microscopic hematuria (non-visible blood in the urine).

Marc Bjurlin, DO, MSC, FCOS
Dr. Bjurlin is a Physician and Researcher within the UNC School of Medicine and UNC Lineberger Comprehensive Cancer Center. His clinical practice is focused on urologic oncology—in particular, the treatment of bladder, prostate, testis, and kidney cancer. In addition to patient care, Dr. Bjurlin participates in research focused on employing advanced surgical procedures including the use of robotic surgery to maximize the quality of life for people with urologic malignancies.

Recently, Dr. Bjurlin has received two separate funding awards for studying the effects of e-cigarette use. Dr. Bjurlin received the UNC Lineberger Innovation Award for evaluating the carcinogenic effects of e-cigarettes on the urothelium and also received funding through NC TraCS and NYU to characterize carcinogenic biomarkers found in the urine of young adult e-cigarette users.